The field of HIV/AIDS is rapidly changing and, more than at any time in the past, there is now an unprecedented opportunity to bring the HIV epidemic under control, to drive down HIV incidence on a national and international scale, and to greatly reduce the burden of HIV/AIDS through emerging biomedical and multi-level intervention approaches. Doing so will require a new generation of scientific research that integrates the most recent advances in the medical, behavioral, and social HIV prevention fields. Experts and funding agencies throughout the world agree upon this need for integration and transformation in the HIV field.
There is much yet to develop and test with these new biomedical and multi-level interventions, as well as next generation interventions to create. The CAIR Research Conference will facilitate CAIR’s mission of reducing HIV incidence, demonstrating intervention effectiveness, and reducing HIV-related health disparities by exposing CAIR investigators, CAIR affiliates, and staff to expert speakers on issues related to these emerging biomedical and technology advances. The CAIR Research Conference has been a longstanding educational opportunity for all persons at CAIR to shape and guide research programming and generate novel research agendas. In addition, all CAIR conferences are open to the public to foster wider discussion of these advances in the area, and how agencies are or can incorporate the latest developments.
The primary variables we are targeting with the 2015 CAIR Conference are knowledge and performance. As already mentioned, many of these interventions are relatively new and much yet needs to be discovered. For example, we know that highly active anti-retroviral therapy (HAART) regimens can do much to keep individual infections under control. But, what is not known (and what CAIR is attempting to do) is how best to assist individuals in remaining adherent to these HAART regimens over the course of a person’s lifetime. This topic requires new knowledge and performance (i.e., researchers must know what the regimens are, what the latest findings are re: successful adherence, and/or must design behavioral components that support adherence to these regimens).
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement: The Medical College of Wisconsin designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Psychology CE Credit Statement
The Medical College of Wisconsin is approved by the American Psychological Association to sponsor continuing education for psychologists. The Medical College of Wisconsin maintains responsibility for this program and its content.
This activity contains content or processes that may be potentially stressful.
Allied Health Care Professionals
- Given a specific population at risk for HIV infection, outline characteristics of the population’s risk behaviors, as shown in research.
- Given a specific population at risk for HIV infection, describe prevention strategies that have been scientifically proven to be effective.
- Given a specific HIV prevention strategy or technique, discuss advantages and disadvantages to its implementation, as cited in research.
- Given a specific HIV prevention strategy or technique, critique its possible use and effectiveness in new ways, as recommended by national (e.g., CDC) and international (e.g., WHO) health organizations.
Activity Director: Carol L. Galletly, JD, PhD
Andrew E. Petroll, MD, MS
Jeffrey A. Kelly, PhD
Kevin D. Brown, MA
All persons in control of content have NO relevant financial relationships to disclose.